JNJ Johnson & Johnson

  1. Stocks
  2. Healthcare
  3. NYSE: JNJ

Price (delayed)

$278.33

Market cap

$670.75B

P/E Ratio

31.88

Dividend/share

$5.28

EPS

$8.73

Enterprise value

$699.36B

?
Relative Growth: Rel. Growth: 64
Relative Strength: Rel. Strength: 81
Relative Valuation: Rel. Valuation: 27
Relative Profitability: Rel. Profitability: 87

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments ...

Highlights
Johnson & Johnson's debt has decreased by 11% from the previous quarter and by 3.4% YoY
JNJ's revenue is up by 8% year-on-year
JNJ's price to earnings (P/E) is 47% higher than its 5-year quarterly average of 21.5 and 36% higher than its last 4 quarters average of 23.1
Johnson & Johnson's net income has decreased by 7% YoY
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.jnj.com
Peers: PFE MRK NVS SYK

Key stats

What are the main financial stats of JNJ

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
1.13%
1 week
4.73%
1 month
9.4%
1 year
56.37%
YTD
34.49%
QTD
9.59%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$97.93B
Gross profit
$66.5B
Operating income
$25.93B
Net income
$21.04B
Gross margin
67.9%
Net margin
21.5%
The operating income rose by 21% year-on-year
Johnson & Johnson's net margin has decreased by 14% YoY
Johnson & Johnson's operating margin has increased by 12% YoY
JNJ's revenue is up by 8% year-on-year

Price vs fundamentals

How does JNJ's price correlate with its fundamentals

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
JNJ P/E details
P/E
31.88
P/B
7.89
P/S
6.84
EV/EBIT
26.69
EV/EBITDA
20.59
EV/Sales
7.14
JNJ's price to earnings (P/E) is 47% higher than its 5-year quarterly average of 21.5 and 36% higher than its last 4 quarters average of 23.1
The EPS has contracted by 7% YoY
JNJ's price to book (P/B) is 34% more than its 5-year quarterly average of 5.8 and 20% more than its last 4 quarters average of 6.5
JNJ's equity is up by 8% year-on-year and by 4.7% since the previous quarter
The price to sales (P/S) is 33% more than the 5-year quarterly average of 5.1 and 21% more than the last 4 quarters average of 5.6
JNJ's revenue is up by 8% year-on-year

Efficiency

How efficient is Johnson & Johnson business performance
Johnson & Johnson's return on invested capital has decreased by 20% YoY
The company's return on equity fell by 15% YoY and by 2.3% QoQ
The ROS has contracted by 14% YoY
The return on assets has declined by 13% year-on-year

Dividends

What is JNJ's dividend history
Dividend details
DPS
$5.28
Dividend yield
1.9%
Payout ratio
60.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 73% greater than its total liabilities
JNJ's current ratio is up by 8% year-on-year and by 6% since the previous quarter
The quick ratio has increased by 7% YoY and by 6% QoQ
Johnson & Johnson's debt is 42% less than its equity
The company's debt to equity fell by 15% QoQ and by 11% YoY
Johnson & Johnson's debt has decreased by 11% from the previous quarter and by 3.4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.